Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron dose-finding in overactive bladder
NCT00527033Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Sep 2007; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00527033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527033.